Authentidate Announces Name Change to AEON Global Health Corp to Reflect Broader Healthcare Focus and Innovative Solutions
GAINESVILLE, Ga
Read More
-
New Trading Symbol “AGHC” Effective February 1, 2018 Gainesville, GA – January 31, 2018 – Authentidate Holding Corp. (OTCQB: ADAT), announced today that it has completed its previously announced corporate name change to Aeon Global Health Corp. The name change is effective immediately. In addition, effective as of the start of trading on February 1, 2018, our common stock will begin being quoted
Read More -
Aeon Global Health Announces Exclusive Marketing and Sales Agreement for Trusted Branded Pharmaceutical
GAINESVILLE, Ga
Company to market non-opiate pain management drug along with its drug monitoring services to physicians and healthcare facilities on nationwide basis
Read More -
Aeon Global Health Announces Medi-Cal Provider Agreement
Authentidate Holding Corp.
GAINESVILLE, Ga., Aug. 28, 2017 /PRNewswire/ -- Authentidate Holding Corp. (OTCQB: ADAT), a growth oriented company focused on developing and providing clinically actionable medical information and telemedicine services, announced today that Aeon Global Health's clinical laboratory has been selected to become a provider to the California Medicaid Program (Medi-Cal).
Read More -
AUTHENTIDATE HOLDING CORP Files SEC form 8-K, Entry into a Material Definitive Agreement, Financial Statements
ADAt files SEC form 8-K
As previously reported, (i) on November 18, 2015, Authentidate Holding Corp. (the "Company") entered into an agreement and plan of merger with and a newly formed acquisition subsidiary of the Company and Peachstate Health Management LLC, d/b/a AEON Clinical Laboratories ("AEON"), (ii) on January 26, 2016, the parties executed an Amended and Restated Agreement and Plan of Merger.
Read More -
Authentidate Holding Corp. Announces Reverse Stock Split
Common stock will begin trading on a split-adjusted basis on January 25, 2016 Stockholders also Approve Amendment to Certificate of Incorporation to Preserve Tax Benefits
Authentidate Holding Corp. (Nasdaq: ADAT) today announced a 1-for-9 reverse split of its common stock. The reverse stock split will become effective at 5:00 p.m. Eastern Time today, January 22, 2016 and Authentidate’s common stock will begin trading on The NASDAQ Capital Market on a split-adjusted basis when the market opens on January 25, 2016.
Read More -
Authentidate and AEON Clinical Laboratories Enter Into Non-Binding Letter Of Intent to Merge
Authentidate Holding Corp. and AEON Clinical Laboratories today announced that the companies have entered into a non-binding letter of intent (the “Letter of Intent”) for the acquisition of all of the outstanding membership interests of AEON in exchange for shares of a newly created class of Series E Preferred Stock of Authentidate (the “Series E Shares”).
Read More -
Authentidate Holding Corp. and AEON Clinical Laboratories Announce Execution of Definitive Merger Agreement
Authentidate Holding Corp. (NASDAQ: ADAT) and Peachstate Health Management, LLC d/b/a AEON Clinical Laboratories today announced that they have entered into a definitive merger agreement under which privately-held AEON will merge with a wholly-owned subsidiary of Authentidate in exchange for shares of a newly created class of Series E Preferred Stock of Authentidate.
Read More -
Authentidate and AEON Clinical Laboratories Complete Merger to Form Innovative Healthcare Technology Company
Sonny Roshan to serve as Chairman of the Board; Richard Hersperger appointed CEO of the combined Company
Authentidate Holding Corp. and AEON Clinical Laboratories, today announced that they have completed their merger transaction whereby privately-held AEON has merged with a wholly-owned subsidiary of Authentidate. The merger creates a company focused on delivering innovative solutions that achieve technology best practices in medicine and raise the standard of healthcare.
Read More